Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein
Open Access
- 13 January 2020
- journal article
- research article
- Published by Elsevier BV in Virus Research
- Vol. 278, 197863
- https://doi.org/10.1016/j.virusres.2020.197863
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health and Welfare (HI15C2971)
This publication has 31 references indexed in Scilit:
- Transmission of MERS-Coronavirus in Household ContactsThe New England Journal of Medicine, 2014
- Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal AntibodiesJournal of Virology, 2014
- Identification of a Receptor-Binding Domain in the S Protein of the Novel Human Coronavirus Middle East Respiratory Syndrome Coronavirus as an Essential Target for Vaccine DevelopmentJournal of Virology, 2013
- Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study GroupJournal of Virology, 2013
- Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4Cell Research, 2013
- A Simple Methodology for Conversion of Mouse Monoclonal Antibody to Human-Mouse Chimeric FormJournal of Immunology Research, 2013
- Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in HumansmBio, 2012
- Multivalent HA DNA Vaccination Protects against Highly Pathogenic H5N1 Avian Influenza Infection in Chickens and MicePLOS ONE, 2008
- Lysis of Human Immunodeficiency Virus Type 1 by a Specific Secreted Human Phospholipase A2Journal of Virology, 2007
- Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.Proceedings of the National Academy of Sciences of the United States of America, 1996